DocSym
β
Searchsearch
Search
(A81.1) Subacute sclerosing panencephalitis
More details coming soon
34 594 in individuals diagnosis subacute sclerosing panencephalitis confirmed
23 959 deaths with diagnosis subacute sclerosing panencephalitis
69% mortality rate associated with the disease subacute sclerosing panencephalitis
Diagnosis subacute sclerosing panencephalitis is diagnosed Women are 13.30% more likely than Men
14 997
Men receive the diagnosis subacute sclerosing panencephalitis
11 649 (77.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
19 597
Women receive the diagnosis subacute sclerosing panencephalitis
12 310 (62.8 %)Died from this diagnosis.
Risk Group for the Disease subacute sclerosing panencephalitis - Men aged 70-74 and Women aged 65-69
In Men diagnosis is most often set at age 5-9, 20-24, 30-89
Less common in men the disease occurs at Age 0-5, 10-19, 25-29, 90-95+Less common in women the disease occurs at Age 0-1, 5-14, 25-29, 90-95+
In Women diagnosis is most often set at age 0-5, 15-24, 30-89
Disease Features subacute sclerosing panencephalitis
Absence or low individual and public risk
Subacute sclerosing panencephalitis - what does this mean
Subacute sclerosing panencephalitis is a rare and fatal neurological disorder caused by infection with a mutated form of the measles virus. it is characterized by progressive damage to the brain, resulting in behavioral changes, seizures, and eventually coma and death.
What happens during the disease - subacute sclerosing panencephalitis
Subacute sclerosing panencephalitis (sspe) is an extremely rare neurological disorder caused by a persistent infection of the measles virus. it is thought to be caused by a defective virus that is able to survive in the body for a prolonged period of time, leading to an immune response that causes inflammation and damage to the brain. this damage is progressive and leads to a variety of neurological symptoms, including seizures, cognitive and behavioral changes, and ultimately death.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Examination
- Neurological Examination
- MRI Scan
- CT Scan
- EEG
- Lumbar Puncture
- Blood Tests
- Urine Tests
- CSF Analysis
- Genetic Testing
Treatment and Medical Assistance
Main Goal of Treatment: To slow the progression of Subacute Sclerosing Panencephalitis (SSPE)
- Administering immunoglobulin therapy
- Administering antiviral drugs
- Administering anticonvulsants to reduce seizures
- Providing supportive care to manage symptoms
- Providing physical and occupational therapy
- Administering nutritional support
- Administering medications to reduce agitation and aggression
- Monitoring for any changes in behavior or symptoms
- Providing emotional support for the patient and their family
46 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Subacute sclerosing panencephalitis - Prevention
Subacute sclerosing panencephalitis is a rare, progressive, neurological disorder that is caused by a virus and is preventable through immunization. vaccines for measles, mumps, and rubella are available and should be administered to all people, especially children, to help prevent the spread of this disease.